Plasmodium vivax: clinical spectrum, risk factors and pathogenesis

scientific article

Plasmodium vivax: clinical spectrum, risk factors and pathogenesis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/B978-0-12-397900-1.00003-7
P698PubMed publication ID23199488

P50authorRichard PriceQ42591886
Nicholas M. DouglasQ55175709
Nicholas M AnsteyQ60043835
Jeanne Rini PoespoprodjoQ60043853
P2860cites workComparative genomics of the neglected human malaria parasite Plasmodium vivaxQ22122202
P921main subjectPlasmodium vivaxQ311376
pathogenesisQ372016
maternal healthQ6786626
P304page(s)151-201
P577publication date2012-01-01
P13046publication type of scholarly workreview articleQ7318358
P1433published inAdvances in ParasitologyQ15764504
P1476titlePlasmodium vivax: clinical spectrum, risk factors and pathogenesis
P478volume80

Reverse relations

cites work (P2860)
Q35877857A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions
Q33412049A case of vivax malaria complicated by adult respiratory distress syndrome and successful management with extracorporeal membrane oxygenation
Q45794588A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy
Q37425725Analysis of lymphocytes in patients with Plasmodium vivax malaria and its relation to the annexin-A1 and IL-10.
Q56342079Analysis of the lymphocyte cell population during malaria caused by Plasmodium vivax and its correlation with parasitaemia and thrombocytopaenia
Q33417944Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia
Q55426170Anti-band 3 and anti-spectrin antibodies are increased in Plasmodium vivax infection and are associated with anemia.
Q33828552Asia-Pacific malaria is singular, pervasive, diverse and invisible
Q28550280Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia
Q26786117Association between anthropometry-based nutritional status and malaria: a systematic review of observational studies
Q38614220Case Report: Severe and Complicated Cynomolgi Malaria in a Rhesus Macaque Resulted in Similar Histopathological Changes as Those Seen in Human Malaria.
Q93211728Circulating Neutrophil Extracellular Traps and Neutrophil Activation Are Increased in Proportion to Disease Severity in Human Malaria
Q37098382Comparison of parasite sequestration in uncomplicated and severe childhood Plasmodium falciparum malaria
Q36109722Complicated malaria symptoms associated with Plasmodium vivax among patients visiting health facilities in Mendi town, Northwest Ethiopia
Q38844689Could Plasmodium vivax malaria trigger malnutrition? Revisiting the Bradford Hill criteria to assess a causal relationship between two neglected problems
Q56359213Cytotoxic CD8 T cells recognize and kill Plasmodium vivax-infected reticulocytes
Q36318958DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients.
Q33563151Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles
Q38597276Development of vaccines for Plasmodium vivax malaria
Q53767337Diagnosis and Treatment of Plasmodium vivax Malaria
Q92249482Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials
Q37239183Distribution of Antibodies Specific to the 19-kDa and 33-kDa Fragments of Plasmodium vivax Merozoite Surface Protein 1 in Two Pathogenic Strains Infecting Korean Vivax Malaria Patients.
Q33891805Dynamics of Plasmodium vivax sporogony in wild Anopheles stephensi in a malaria-endemic region of Western India
Q38892525Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation
Q37630317Emerging Pathogens - How Safe is Blood?
Q96137089Empiric Treatment for Suspected Malaria in the United States: A Case Report
Q35829555Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
Q36418183Falling Plasmodium knowlesi Malaria Death Rate among Adults despite Rising Incidence, Sabah, Malaysia, 2010-2014.
Q35962523Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years
Q30249044Global Epidemiology of Plasmodium vivax
Q34259032Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Q33721887Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal
Q41722962Heterologous expression of Plasmodium vivax apical membrane antigen 1 (PvAMA1) for binding peptide selection.
Q54208945High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia.
Q34234390Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis
Q28355362Implications of Plasmodium vivax Biology for Control, Elimination, and Research
Q39316977Imported Plasmodium vivax malaria ex Pakistan
Q35564511Incidence of Jaundice in Plasmodium vivax Malaria: A Prospective Study in Moodabidri, South India
Q34142735Influence of age on the haemoglobin concentration of malaria-infected patients in a reference centre in the Brazilian Amazon
Q38260972Innate sensing of malaria parasites
Q37643622KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro
Q28081463Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax
Q36531296Limitations of microscopy to differentiate Plasmodium species in a region co-endemic for Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi
Q28537653Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study
Q56383949Malaria
Q55463707Malaria Elimination: Time to Target All Species.
Q40055950Malaria Pathogenesis
Q35678578Malaria and immunity during pregnancy and postpartum: a tale of two species
Q35712522Malaria eradication and elimination: views on how to translate a vision into reality
Q64962925Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study.
Q37488090Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection.
Q34640080Malaria-induced splenic infarction
Q42338471Management of Plasmodium vivax risk and illness in travelers
Q41996386Metabolome-wide association study of peripheral parasitemia in Plasmodium vivax malaria
Q37642896Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West Cameroon
Q34686612Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia
Q95818239Natural Products as Sources of Antimalarial Drugs: Ethnobotanical and Ethnopharmacological Studies
Q36560001New insights into the Plasmodium vivax transcriptome using RNA-Seq
Q38892647Nitric Oxide-Dependent Endothelial Dysfunction and Reduced Arginine Bioavailability in Plasmodium vivax Malaria but No Greater Increase in Intravascular Hemolysis in Severe Disease.
Q35328856Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells
Q36063764Optimization of a Membrane Feeding Assay for Plasmodium vivax Infection in Anopheles albimanus
Q35682623Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
Q60947070Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria
Q33419656Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria
Q47799735Pathophysiology, clinical presentation, and treatment of coma and acute kidney injury complicating falciparum malaria
Q42659378Pernicious and threatening Plasmodium vivax as reality
Q33435123Plasmodium cynomolgi infections in rhesus macaques display clinical and parasitological features pertinent to modelling vivax malaria pathology and relapse infections
Q39530831Plasmodium falciparum, but not P. vivax, can induce erythrocytic apoptosis
Q33741840Plasmodium vivax Induced Acute Respiratory Distress Syndrome - A Diagnostic and Therapeutic Dilemma in Preeclampsia
Q35847037Plasmodium vivax Transmission in Africa
Q37633527Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice
Q56358763Platelets kill circulating parasites of all major Plasmodium species in human malaria
Q58115290Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework
Q35649424Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection
Q30248811Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria
Q33731882Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency
Q38672428Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis
Q37045828Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland
Q35921902Sensitive Detection of Plasmodium vivax Using a High-Throughput, Colourimetric Loop Mediated Isothermal Amplification (HtLAMP) Platform: A Potential Novel Tool for Malaria Elimination
Q37433398Stuck in a rut? Reconsidering the role of parasite sequestration in severe malaria syndromes
Q36176399Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia
Q36003145Symptoms and Immune Markers in Plasmodium/Dengue Virus Co-infection Compared with Mono-infection with Either in Peru
Q58089503Tafenoquine for travelers' malaria: evidence, rationale and recommendations
Q40218474The Biology of Plasmodium vivax
Q27009149The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon
Q28551039The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with Malaria
Q34969275The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea
Q30619692The fluid management of adults with severe malaria
Q34874961The importance of pathogen load
Q35068767The prognostic utility of bedside assessment of adults hospitalized with malaria in Myanmar: a retrospective analysis
Q89786563The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
Q48022024Tissue-specific immunopathology during malaria infection
Q28607891Towards a strategy for malaria in pregnancy in Afghanistan: analysis of clinical realities and women's perceptions of malaria and anaemia
Q33713142Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome
Q38603812Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
Q36952579Vivax malaria and bacteraemia: a prospective study in Kolkata, India

Search more.